Skip to main content
. 2024 Feb 1;14:2719. doi: 10.1038/s41598-024-52782-1

Figure 1.

Figure 1

Schematic illustration of elevated serum levels of biomarkers (after sensitivity analyses) for: (a) patients vs. controls; (b) patients with Raynaud’s phenomenon (RP) vs. patients without RP; (c) patients without RP vs. controls without RP.